Can Your Genomics Work Contribute to Biodefense Three years ago, Luis Villarreal, a virologist at the University of California, Irvine, came up with the idea of using in vitro gene activation by PCR to study the proteome of a virus in hopes of developing a high-throughput platform for identifying new vaccines. Villarreal and his collaborators […]
Biogen/Idec: still a matter of size The merger of Biogen and Idec Pharmaceuticals, announced June 23, is likely to help the two relatively isolated companies increase presence in their disease areas. The annual R&D budget for the new pharmaceutical entity, to be called Biogen Idec Inc, will be $500 million, according to company reports.
The State of Biotechnology Researchers, government officials and industry executives will gather this weekend in Washington for the Biotechnology Industry Organization’s annual convention. Topics to be addressed at BIO 2003 range from science and regulatory affairs to bioethics and homeland security.
Coffee Plants Can Produce Less Caffeine Researchers say they have genetically engineered coffee plants that have 70 percent less caffeine than usual in their leaves. The crucial question for brewing coffee � whether beans from those plants will have less caffeine � won’t be known for three to four years when the plants mature
Pfizer’s Outlook Improves Having spent $5 billion on research and development in 2002, Pfizer (NYSE: PFE) is king of the drug world. And with its $60 billion Pharmacia merger completed in April, the king just got fatter
Schering’s Dr. Feelbetter? Fred Hassan is out to revive the drugmaker. It’s a big job
FDA approves first nasal mist flu vaccine Most people who avoid flu shots because they fear needles will not have that excuse this season. The Food and Drug administration has approved a flu vaccine that is delivered by a squirt up the nose instead of a shot in the arm.
Microsoft loses No. 2 ranking in market value to drug maker Microsoft has lost its status as the world’s second-largest corporation to drug maker Pfizer due to slowing sales growth that caused it to miss out on this year’s stock-market rally.
Report Says More Farmers Don’t Follow Biotech Rules A new study, drawn from government data, shows that more farmers are failing to comply with standards governing the planting of genetically modified corn than the industry has claimed. Nearly one-fifth of farms growing the main type of genetically engineered corn, BT corn, are violating government rules […]
More regulations for biotech products aren’t necessary, FDA says Genetically engineered foods from crops that have already been reviewed and approved by two government agencies shouldn’t have to jump through a third regulatory hoop at the Food and Drug Administration, an FDA official told Congress Tuesday.